Article Details

Medtronic Receives US FDA Approval for Pipeline Flex Embolization Device with Shield Technology

Retrieved on: 2021-04-21 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Medtronic Receives US FDA Approval for Pipeline Flex Embolization Device with Shield Technology. View article details on hiswai:

Excerpt

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug ...

Article found on: investingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up